Europe Sepsis Diagnostics Market

The Europe sepsis diagnostics market is expected to grow from US$ 193.12 million in 2021 to US$ 360.55 million by 2028. It is estimated to record a CAGR of 9.3% from 2021 to 2028.

Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches Fuels Europe Sepsis Diagnostics Market Growth

Most of the diagnostic tests for sepsis are time-consuming and take up to 72 hours to provide results. In the era of molecular diagnosis for every kind of disease, the demand for rapid diagnostic tests for sepsis is rising. To fulfil this rising demand, many key players operating in the industry put efforts into developing innovative rapid diagnostic tests for sepsis. In September 2020, Barcelona-based Loop Diagnostics launched a point-of-care diagnosis platform. The platform aimed to replace the traditional methods of blood culture analysis and provide rapid results. Also, it can identify bacterial infections via blood-based markers and provide test results in two hours with a 99% accuracy rate. The cost of the diagnosis with this system is US$ 70. Moreover, the key players developed cost-effective diagnostic tests to overcome all the challenges associated with sepsis diagnosis. Inflammatix, a pioneering molecular diagnostics company, announced the publication of a health economic model. The model shows that the use of the company's HostDxTM Sepsis test is cost-effective as compared to standard methods. The test was performed on patients suspected of acute respiratory tract infections (ARTI) in emergency departments. The study was published in April 2020 in The Journal of Health Economics and Outcomes Research. The model informed hospital clinicians of the potential clinical and economic benefits of widespread adoption of the HostDx Sepsis test. Thus, the rising demand for rapid diagnostics tests led to product launches, which is expected to drive the Europe sepsis diagnostics market during the forecast period.

Europe Sepsis Diagnostics Market Overview

The Europe sepsis diagnostics market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The Germany holds a significant market share in the Europe sepsis diagnostics market and is estimated to register a robust growth rate over the forecast period. Germany and the UK are expected to contribute majorly to the growth of the market in Europe. The Europe sepsis diagnostics market is expected to witness a significant growth during the forecast period due to factors such as the need for early diagnosis of sepsis, the high mortality rate of the medical condition, and its increasing prevalence.

Europe Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Europe Sepsis Diagnostics Strategic Insights

Strategic insights for the Europe Sepsis Diagnostics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Sepsis Diagnostics Report Scope

Europe Sepsis Diagnostics Regional Insights

The geographic scope of the Europe Sepsis Diagnostics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Europe Sepsis Diagnostics Market Segmentation

The Europe sepsis diagnostics market is segmented the basis of product, technology, method, test type, pathogen, end user, and country.

Based on product, the Europe sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.

Based on technology, the Europe sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.

Based on method, the Europe sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.

Based on test type, the Europe sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.

Based on pathogen, the Europe sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.

Based on end user, the Europe sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.

Based on country, the Europe sepsis diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and Rest of Europe. Germany dominated the market share in 2021.

Abbott; Axis-Shield Diagnostics Ltd; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; Luminex Corporation; T2 Biosystems, Inc.; and THERMO FISHER SCIENTIFIC INC.are among the leading companies operating in the Europe sepsis diagnostics market.